Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies
Clinical & Experimental Allergy · 2024
DOI: 10.1111/cea.14448 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2024. Verfasst von Maria R Strobl und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Aus…. Hauptthemen laut MEDLINE: Immunoglobulin E, Hypersensitivity. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Medizinische Universität Wien, Austrian Science Fund.
Abstract (Originalsprache)
Introduction
Allergen‐specific IgE‐blocking IgG antibodies contribute to successful allergen immunotherapy (AIT), however, not much is known about their affinity. Since affinity measurements of polyclonal antibodies in serum are technically challenging we evaluated the applicability of acidic disruption of antibody‐allergen complexes by a modified ELISA protocol with monoclonal antibodies (mAbs) specific for the relevant major allergens Betv1 and Mald1. Then, AIT‐induced blocking and non‐blocking Mald1‐specific antibodies in sera from individuals with or without reduced apple allergy were compared.
Methods
After testing their pH stability coated recombinant allergens were incubated with (i) mAbs diluted in PBS or human serum and (ii) sera from individuals after sublingual administration of Mald1 or Betv1 for 16 weeks. Immune complexes were exposed to buffers in the pH range of 6.4–3.4 and residual antibodies were measured. Avidity indexes (AI), defined as the pH removing 50% of antibodies, were compared to the dissociation constants ( K D ) of mAbs determined by surface plasmon resonance.
Results
The selected pH range was applicable to disrupt allergen complexes with highly affine mAbs without compromising allergen integrity. AIs of mAbs accorded with K D values and were unaffected by epitope specificity or the presence of serum proteins. The inter‐assay variability was
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
- Department of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria.
- Molecular Allergology, Paul-Ehrlich-Institute, Langen, Germany.
ORCID-Profile: Andrea Wangorsch, Barbara Bohle
Förderung
- Austrian Science Fund FWF
- Medizinische Universität Wien
- Austrian Science Fund
- Danube Allergy Research Cluster
Zitieren
APA
Strobl, M. R., Demir, H., Wozniak-Knopp, G., Wangorsch, A., Rüker, F., & Bohle, B. (2024). Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14448
Vancouver
Strobl MR, Demir H, Wozniak-Knopp G, Wangorsch A, Rüker F, Bohle B. Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies. Clinical & Experimental Allergy. 2024. doi:10.1111/cea.14448
BibTeX
@article{Strobl2024,
author = {Strobl, Maria R and Demir, Hilal and Wozniak-Knopp, Gordana and Wangorsch, Andrea and Rüker, Florian and Bohle, Barbara},
title = {Easy assessment of the avidity of polyclonal allergen‐specific serum antibodies},
journal = {Clinical & Experimental Allergy},
year = {2024},
doi = {10.1111/cea.14448}
}
EUVIMED